(Q39018543)

8 September 2017

title

Radiofluorination of PSMA-HBED via Al(18)F(2+) Chelation and Biological Evaluations In Vitro (English)

1 reference

8 September 2017

Noeen Malik

1

1 reference

8 September 2017

Benjamin Baur

2

1 reference

8 September 2017

Gordon Winter

3

1 reference

8 September 2017

Sven N Reske

4

1 reference

8 September 2017

Ambros J Beer

5

1 reference

8 September 2017

Christoph Solbach

6

1 reference

8 September 2017

publication date

14 April 2015

1 reference

Molecular Imaging and Biology

8 September 2017

published in

1 reference

8 September 2017

volume

17

1 reference

8 September 2017

issue

6

1 reference

8 September 2017

page(s)

777-785

1 reference

https://scigraph.springernature.com/pub.10.1007/s11307-015-0844-6

8 September 2017

exact match

0 references

cites work

Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

Comment on Afshar-Oromieh et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

N-substituted glutamyl sulfonamides as inhibitors of glutamate carboxypeptidase II (GCP2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

Clinical trials of cancer therapies targeting prostate-specific membrane antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

Design, synthesis, and preclinical evaluation of prostate-specific membrane antigen targeted (99m)Tc-radioimaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

Direct one-step 18F-labeling of peptides via nucleophilic aromatic substitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

A novel facile method of labeling octreotide with (18)F-fluorine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

Synthesis and biological analysis of prostate-specific membrane antigen-targeted anticancer prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

One step radiosynthesis of 6-[(18)F]fluoronicotinic acid 2,3,5,6-tetrafluorophenyl ester ([(18)F]F-Py-TFP): a new prosthetic group for efficient labeling of biomolecules with fluorine-18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

Improved 18F labeling of peptides with a fluoride-aluminum-chelate complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

High-yielding aqueous 18F-labeling of peptides via Al18F chelation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

The radiolabeling of proteins by the [18F]AlF method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

New lyophilized kit for rapid radiofluorination of peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

Radiofluorination using aluminum-fluoride (Al18F)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

First experience of 18F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

Is prostate-specific membrane antigen a multifunctional protein?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

Ternary hydroxide complexes in neutral solutions of Al3+ and F-.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-015-0844-6

Interaction of prostate specific membrane antigen with clathrin and the adaptor protein complex-2

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25869080

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Radiosynthesis of a new PSMA targeting ligand ([18F]FPy-DUPA-Pep)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25869080

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11307-015-0844-6

1 reference

8 September 2017

1 reference